As for the de novo pathway, DHCR24 was higher in compact tumor cells (Table 1) but there were no significant correlations detected between the morphological parameter (the percentage of compact cells) and de novo pathway activities (Table 2). This evidence concerns the gene DHCR24 and neoplasm.